Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Dec;7(Suppl 3):S309-S319.
doi: 10.21037/cdt.2017.10.08.

Deep venous thrombosis in pregnancy: incidence, pathogenesis and endovascular management

Paola Devis  1 , M Grace Knuttinen  2
Affiliations
Review

Deep venous thrombosis in pregnancy: incidence, pathogenesis and endovascular management

Paola Devis et al. Cardiovasc Diagn Ther. 2017 Dec.

Abstract

Deep venous thrombosis (DVT) during pregnancy is associated with high mortality, morbidity, and costs. Pulmonary embolism (PE), its most feared complication, is the leading cause of maternal death in the developed world. DVT can also result in long-term complications that include postthrombotic syndrome (PTS) adding to its morbidity. Women are up to 5 times more likely to develop DVT when pregnant. The current standard of care for this condition is anticoagulation. This review discusses the epidemiology, pathogenesis, prophylaxis and diagnosis of DVT during pregnancy, and then focuses on endovascular treatment modalities. Inferior vena cava (IVC) filter placement and pharmacomechanical catheter directed thrombolysis (PCDT) in the pregnant patient are discussed, as well as patient selection criteria, and complications.

Keywords: Deep vein thrombosis; risk factor; unfractionated heparin (UFH).

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Marik PE, Plante LA. Venous thromboembolic disease in pregnancy. N Engl J Med 2008;359:2025. 10.1056/NEJMra0707993 - DOI - PubMed
    1. Kujovich JL. Hormones and pregnancy: thromboembolic risks for women. BR J Haematol 2004;126:443. 10.1111/j.1365-2141.2004.05041.x - DOI - PubMed
    1. Heit JA, Kobbervig CE, James AH, et al. Trends in the incidence of venous thromboembolism during pregnancy and postpartum: a 30 year population based study. Ann Int Med 2005;143:697. 10.7326/0003-4819-143-10-200511150-00006 - DOI - PubMed
    1. James AH, Jamison MG, Brancazio LR, et al. Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors and mortality. Am J Obstet Gynecol 2006;194:1311. 10.1016/j.ajog.2005.11.008 - DOI - PubMed
    1. Simpson EL, Lawrenson RA, Nightingale AL, et al. Venous Thromboembolism in pregnancy and the puerperium: incidence and additional risk factors from a London perinatal database. BJOG 2001;108:56-60. 10.1111/j.1471-0528.2001.00004.x - DOI - PubMed

LinkOut - more resources